CN103880837A - Synthetic method of cimetropium bromide - Google Patents

Synthetic method of cimetropium bromide Download PDF

Info

Publication number
CN103880837A
CN103880837A CN201410116250.1A CN201410116250A CN103880837A CN 103880837 A CN103880837 A CN 103880837A CN 201410116250 A CN201410116250 A CN 201410116250A CN 103880837 A CN103880837 A CN 103880837A
Authority
CN
China
Prior art keywords
cimetropium bromide
synthetic method
water
cimetropium
bromide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410116250.1A
Other languages
Chinese (zh)
Inventor
彭学东
张梅
赵金召
陈晓龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHANGJIAGANG WEISHENG BIOLOGICAL PHARMACEUTICAL CO Ltd
Original Assignee
ZHANGJIAGANG WEISHENG BIOLOGICAL PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZHANGJIAGANG WEISHENG BIOLOGICAL PHARMACEUTICAL CO Ltd filed Critical ZHANGJIAGANG WEISHENG BIOLOGICAL PHARMACEUTICAL CO Ltd
Priority to CN201410116250.1A priority Critical patent/CN103880837A/en
Publication of CN103880837A publication Critical patent/CN103880837A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention belongs to the technical field of organic synthesis and specifically relates to a synthetic method of cimetropium bromide. The synthetic method comprises the following steps of stirring scopolamine hydrobromide and water, dropwise adding saturated potassium carbonate liquor under an ice bath, extracting by applying dichloromethane, washing with water after extracting, adding cyclopropylmethyl bromide, reacting under refluxing, cooling and separating out crystals, and carrying out suction-filtering and re-crystallizing to obtain cimetropium bromide, wherein total yield is over 50%. The synthetic method disclosed by the invention adopts dichloromethane as a single reaction organic solvent, so that reaction steps are simplified, dichloromethane can be recycled, and therefore, production cost is lowered, and environmental pollution is reduced.

Description

A kind of synthetic method of cimetropium bromide
Technical field
The invention belongs to technical field of organic synthesis, be specifically related to a kind of synthetic method of cimetropium bromide.
Background technology
Cimetropium bromide, its chemistry bromination 8-by name encircles the third methyl-6, and 7-epoxy-3-hydroxyl-1 α H-tropane-(-) tropate, has another name called bromination N-(cyclopropyl methyl) Scopolamine, and within 1984, first it go on the market in Italy.Main mechanism is that the muscarinic receptor of blocking-up visceral smooth muscle has Antimuscarinic effect, also can directly act on unstriated muscle, remove smooth muscle spasm etc.Clinically be mainly used in treating biliary colic, cramps of gastrointestinal tract pain, biliary tract and urethrospasm pain, dysmenorrhoea, pain of childbirth and vomiting in children, tell milk, stomachache and pylorospasm.
The synthetic method of the cimetropium bromide of bibliographical information is to make through quaterisation with Scopolamine and brooethyl cyclopropane, but free Scopolamine is unstable, and storage process is easily degraded, and reaction yield is low; Another kind is to use scopolamine hydrobromide to make with brooethyl cyclopropane quaterisation after hydrolysis, but its reaction solvent kind is many, and step is more loaded down with trivial details.
Summary of the invention
The object of the invention is to overcome the above-mentioned shortcoming of prior art, provide a kind of stability high, reactions steps is simple, the synthetic method of the cimetropium bromide that reaction solvent is single.
Concrete, a synthesis technique for cimetropium bromide, it comprises the following steps: by scopolamine hydrobromide, water, stir, under ice bath, drip unsaturated carbonate potassium solution, with dichloromethane extraction, after extraction, wash with water, add brooethyl cyclopropane, back flow reaction, cooling crystallization, suction filtration, recrystallization had both obtained cimetropium bromide.
Scopolamine hydrobromide in above-mentioned preparation method: water weight ratio is about 1:6 ~ 8; After dropping saturated solution of potassium carbonate, adjusting pH is 8 ~ 9; Scopolamine hydrobromide: brooethyl cyclopropane weight ratio is about 1.5 ~ 1.8:1; Return time is 10 ~ 15h.
Embodiment
Embodiment 1:
By 20g scopolamine hydrobromide, 150ml water, stir, under ice bath, drip unsaturated carbonate potassium solution and adjust pH to 8, with 100ml dichloromethane extraction twice, collect methylene dichloride 40ml washing 2 times, add 11g brooethyl cyclopropane, backflow 12h reaction, cooling crystallization, suction filtration, recrystallization had both obtained cimetropium bromide 11.5g, and total recovery is 50%.
Embodiment 2:
By 40g scopolamine hydrobromide, 3000ml water, stir, under ice bath, drip unsaturated carbonate potassium solution and adjust pH to 9, with 200ml dichloromethane extraction twice, collect methylene dichloride 80ml washing 2 times, add 23g brooethyl cyclopropane, backflow 14h reaction, cooling crystallization, suction filtration, recrystallization had both obtained cimetropium bromide 23.2g, and total recovery is 50%.
Embodiment 3:
By 100g scopolamine hydrobromide, 750ml water, stir, under ice bath, drip unsaturated carbonate potassium solution and adjust pH to 9, with 500ml dichloromethane extraction twice, collect methylene dichloride 200ml washing 2 times, add 60g brooethyl cyclopropane, backflow 10h reaction, cooling crystallization, suction filtration, recrystallization had both obtained cimetropium bromide 47.3g, and total recovery is 51%.
Embodiment 4:
By 50g scopolamine hydrobromide, 370ml water, stir, under ice bath, drip unsaturated carbonate potassium solution and adjust pH to 8, with 250ml dichloromethane extraction twice, collect methylene dichloride 100ml washing 2 times, add 28g brooethyl cyclopropane, backflow 15h reaction, cooling crystallization, suction filtration, recrystallization had both obtained cimetropium bromide 28g, and total recovery is 48.3%.

Claims (4)

1. the synthesis technique of a cimetropium bromide, it is characterized in that scopolamine hydrobromide soluble in water, under ice bath, add unsaturated carbonate aqueous solutions of potassium, dichloromethane extraction, adds brooethyl cyclopropane, back flow reaction, be cooled to after completion of the reaction room temperature, obtain cimetropium bromide crude product, by cimetropium bromide recrystallization, obtain cimetropium bromide fine work.
2. the synthesis technique of a kind of cimetropium bromide according to claim 1, is characterized in that scopolamine hydrobromide: water weight ratio is about 1:6 ~ 8.
3. the synthesis technique of a kind of cimetropium bromide according to claim 1, is characterized in that dripping that to adjust pH after saturated solution of potassium carbonate be 8 ~ 9.
4. the synthesis technique of a kind of cimetropium bromide according to claim 1, is characterized in that scopolamine hydrobromide: brooethyl cyclopropane weight ratio is about 1.5 ~ 1.8:1; Reflux time is 10 ~ 15h.
CN201410116250.1A 2014-03-27 2014-03-27 Synthetic method of cimetropium bromide Pending CN103880837A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410116250.1A CN103880837A (en) 2014-03-27 2014-03-27 Synthetic method of cimetropium bromide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410116250.1A CN103880837A (en) 2014-03-27 2014-03-27 Synthetic method of cimetropium bromide

Publications (1)

Publication Number Publication Date
CN103880837A true CN103880837A (en) 2014-06-25

Family

ID=50950003

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410116250.1A Pending CN103880837A (en) 2014-03-27 2014-03-27 Synthetic method of cimetropium bromide

Country Status (1)

Country Link
CN (1) CN103880837A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853886A (en) * 1972-04-18 1974-12-10 Angeli Inst Spa Certain n-substituted scopolammonium compounds
CN101230063A (en) * 2008-02-20 2008-07-30 南昌弘益科技有限公司 Method for preparing tiotropium bromide
CN102146079A (en) * 2011-02-28 2011-08-10 广州瑞尔医药科技有限公司 Preparation method of scopolamine butylbromide
CN103319478A (en) * 2013-05-14 2013-09-25 张家港威胜生物医药有限公司 Synthesis process of important medicinal chemical raw material bromomethyl scopolamine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853886A (en) * 1972-04-18 1974-12-10 Angeli Inst Spa Certain n-substituted scopolammonium compounds
CN101230063A (en) * 2008-02-20 2008-07-30 南昌弘益科技有限公司 Method for preparing tiotropium bromide
CN102146079A (en) * 2011-02-28 2011-08-10 广州瑞尔医药科技有限公司 Preparation method of scopolamine butylbromide
CN103319478A (en) * 2013-05-14 2013-09-25 张家港威胜生物医药有限公司 Synthesis process of important medicinal chemical raw material bromomethyl scopolamine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
柴雨柱 等: "西托溴铵的合成", 《药学与临床研究》 *

Similar Documents

Publication Publication Date Title
CN103382170B (en) Preparation method for taurine
CN102351720B (en) Simple and efficient ambroxol synthesis method
MY167395A (en) Method for producing glufosinate p free acid
CN103524403B (en) A kind of preparation method of doxylamine succinate
CN104016924A (en) One-pot method for synthetizing enzalutamide
CN102964268A (en) Synthesis method of menthyl amide cooling agent
CN103524595A (en) Method for synthesizing pseudo-dipeptide Fmoc-Gly-Thr(phiMe, Me pro)-OH by utilizing new kilogram method
CN102757356B (en) Splitting process of racemic para hydroxybenzene glycine
CN101531654B (en) Preparation method for Rupatadine
CN103880837A (en) Synthetic method of cimetropium bromide
CN107501373B (en) A kind of preparation method of danabol
CN102320933B (en) Method for preparing 4-tert-butyl-2-(alpha-methyl benzyl)phenol
CN102174049A (en) Process for salifying naloxone hydrochloride
RU2006133547A (en) METHOD FOR PRODUCING LYSERGINIC ACID
CN103387528B (en) Resolution method of N-methyl-2(2-hydroxyethyl)pyrrolidine and application thereof
CN102851016B (en) Carboxy-lycine amphoteric surfactant for oil displacement and preparation method thereof
CN104610067B (en) A kind of synthetic method of Rimantadine
CN102093257B (en) Method for preparing 2,2-diisopropylpropionitrile
CN102827161A (en) Method for purifying moxifloxacin
CN103896834A (en) 2-Cyano-3-cyclobutylpyridine and chemical synthesis method thereof
CN101817507B (en) Method for recovering hydrogen chloride gas during production of triethyl orthoformate
CN103833530A (en) Preparation method of organic intermediate 3-phenoxyl-1, 2-propylene glycol
CN105254489B (en) Method for extracting and separating succinic acid
CN102617366B (en) Preparation method of (S)-5-chloro-alpha-(cyclopropyl acetylene)-2-amino-alpha-(trifluoromethyl) benzyl alcohol
CN104230677B (en) A kind of synthetic method of bromo-acetaldehyde diethyl acetal

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140625